Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels

J Pharmacol Exp Ther. 2001 Feb;296(2):573-83.

Abstract

We have studied and compared the effects of bupivacaine with those induced by a new local anesthetic, IQB-9302, on human cardiac K+ channels hKv1.5, Kv2.1, Kv4.3, and HERG. Both drugs have a close chemical structure, only differing in their N-substituent (n-butyl and cyclopropylmethyl, for bupivacaine and IQB-9302, respectively). Both drugs blocked Kv2.1, Kv4.3, and HERG channels similarly. Bupivacaine inhibited these channels by 48.6 +/- 3.4, 45.4 +/- 12.4, and 43.1 +/- 9.1%, respectively, and IQB-9302 by 48.1 +/- 3.3, 36.1 +/- 3.7, and 50.3 +/- 6.6%, respectively. However, bupivacaine was 2.5 times more potent than IQB-9302 to block hKv1.5 channels (EC(50) = 8.9 +/- 1.4 versus 21.5 +/- 4.7 microM). Both drugs induced a time- and voltage-dependent block of hKv1.5 and Kv2.1 channels. Block of Kv4.3 channels induced by either drug was time- and voltage-dependent at membrane potentials coinciding with the activation of the channels. IQB-9302 produced an instantaneous block of Kv4.3 and hKv1.5 channels at the beginning of the depolarizing pulse that can be interpreted as a drug interaction with a nonconducting state. Bupivacaine and IQB-9302 induced a similar degree of block of HERG channels and induced a steep voltage-dependent decrease of the relative current. These results suggest that 1) bupivacaine and IQB-9302 block the open state of hKv1.5, Kv2.1, Kv4.3, and HERG channels; and 2) small differences at the N-substituent of these drugs do not affect the drug-induced block of Kv2.1, Kv4.3, or HERG, but specifically modify block of hKv1.5 channels.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Anesthetics, Local
  • Animals
  • Bupivacaine / pharmacology*
  • Cation Transport Proteins*
  • Cell Line
  • DNA-Binding Proteins*
  • Delayed Rectifier Potassium Channels
  • ERG1 Potassium Channel
  • Electrophysiology
  • Ether-A-Go-Go Potassium Channels
  • Heart / drug effects
  • Humans
  • Kv1.5 Potassium Channel
  • Membrane Potentials / drug effects
  • Myocardium / metabolism*
  • Patch-Clamp Techniques
  • Piperidines / pharmacology*
  • Potassium Channels / drug effects*
  • Potassium Channels / genetics
  • Potassium Channels / metabolism
  • Potassium Channels, Voltage-Gated*
  • Shab Potassium Channels
  • Shal Potassium Channels
  • Trans-Activators*
  • Transcriptional Regulator ERG

Substances

  • Anesthetics, Local
  • Cation Transport Proteins
  • DNA-Binding Proteins
  • Delayed Rectifier Potassium Channels
  • ERG protein, human
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • IQB 9302
  • KCNA5 protein, human
  • KCNB1 protein, human
  • KCND3 protein, human
  • KCNH2 protein, human
  • KCNH6 protein, human
  • Kv1.5 Potassium Channel
  • Piperidines
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Shab Potassium Channels
  • Shal Potassium Channels
  • Trans-Activators
  • Transcriptional Regulator ERG
  • Bupivacaine